{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:01:15Z","timestamp":1761991275510,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007765","name":"Kansas State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006745","name":"Jawaharlal Nehru Technological University Hyderabad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006745","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008418","name":"Guru Angad Dev Veterinary and Animal Sciences University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008418","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jgar.2020.03.019","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T19:45:55Z","timestamp":1586893555000},"page":"116-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Impact of marbofloxacin administration on the emergence of marbofloxacin-resistant E. coli in faecal flora of goats and elucidation of molecular basis of resistance"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1459-6285","authenticated-orcid":false,"given":"Pallavi","family":"Bhardwaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Rampal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2020.03.019_bib0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1086\/422002","article-title":"The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens","volume":"39","author":"Donskey","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2020.03.019_bib0010","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1128\/AAC.45.11.3084-3091.2001","article-title":"Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures","volume":"45","author":"McDonald","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.03.019_bib0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/45.3.295","article-title":"Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America (1998)","volume":"45","author":"Gales","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.03.019_bib0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1051\/vetres:2001124","article-title":"Quinolone resistance in Escherchia coli","volume":"32","author":"Webber","year":"2001","journal-title":"Vet Res"},{"year":"1996","series-title":"Committee for Veterinary Medicinal Productions Marbofloxacin Summary Report (1)","author":"EMEA","key":"10.1016\/j.jgar.2020.03.019_bib0025"},{"year":"2007","series-title":"The United States Pharmacopeia. The national formulary, USP, Fluoroquinolones; veterinary systemic: The United States Pharmacopeial Convention","author":"USP","key":"10.1016\/j.jgar.2020.03.019_bib0030"},{"issue":"8","key":"10.1016\/j.jgar.2020.03.019_bib0035","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","article-title":"Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success","volume":"22","author":"Redgrave","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jgar.2020.03.019_bib0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/trstmh\/trt106","article-title":"Analysis of quinolone resistance in commensal and diarrheagenic Escherichia coli isolates from infants in Lima, Peru","volume":"108","author":"Pons","year":"2013","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jgar.2020.03.019_bib0045","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3906\/vet-1506-74","article-title":"High level fluoroquinolone resistance in Escherichia coli isolated from animals in Turkey is due to multiple mechanisms","volume":"40","author":"Sahint\u00fcrk","year":"2016","journal-title":"Turk J Vet Anim Sci"},{"key":"10.1016\/j.jgar.2020.03.019_bib0050","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3389\/fmicb.2016.02147","article-title":"Characteristics of quinolone resistance in escherichia coli isolates from humans, animals, and the environment in the Czech Republic","volume":"7","author":"R\u00f6derova","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2020.03.019_bib0055","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1128\/AAC.00996-10","article-title":"Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance","volume":"55","author":"Swick","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jgar.2020.03.019_bib0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1292\/jvms.12-0186","article-title":"Contribution of AcrAB-TolC efflux pumps to high- level fluoroquinolone resistance in Escherichia coli isolated from dogs and humans","volume":"75","author":"Toyotaka","year":"2013","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.jgar.2020.03.019_bib0065","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1128\/AEM.00600-11","article-title":"Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food producing animals","volume":"77","author":"Karczmarczyk","year":"2011","journal-title":"Appl Environ Microbiol"},{"year":"1999","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","author":"National Committee for Clinical Laboratory Standards (NCCLS)","key":"10.1016\/j.jgar.2020.03.019_bib0070"},{"issue":"2","key":"10.1016\/j.jgar.2020.03.019_bib0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/vr.100246","article-title":"Survey of marbofloxacin susceptibility of bacteria isolated from cattle with respiratory disease and mastitis in Europe","volume":"170","author":"Kroemer","year":"2012","journal-title":"Vet Rec"},{"key":"10.1016\/j.jgar.2020.03.019_bib0080","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.02855-06","article-title":"Identification of unconventional intestinal pathogenic Escherichia coli isolates expressing intermediate virulence factor profiles by using a novel single-step multiplex PCR","volume":"73","author":"Muller","year":"2007","journal-title":"Appl Environ Microbiol"},{"issue":"7","key":"10.1016\/j.jgar.2020.03.019_bib0085","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1128\/AAC.01612-09","article-title":"Emergence of resistant Klebsiella pneumoniae in the intestinal tract during successful treatment of Klebsiella pneumoniae lung infection in rats","volume":"54","author":"Kesteman","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.03.019_bib0090","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1086\/600122","article-title":"Ciprofloxacin dosage and emergence of resistance in human commensal bacteria","volume":"200","author":"Fantin","year":"2009","journal-title":"J Infect Dis"},{"year":"2013","series-title":"Performance standards for Antimicrobial disk and Dilution Susceptibility Tests for Bacteria isolated from Animals. Approved Standard\u2013Fourth edition. CLSI document VET01-A4","author":"CLSI","key":"10.1016\/j.jgar.2020.03.019_bib0095"},{"key":"10.1016\/j.jgar.2020.03.019_bib0100","first-page":"70","article-title":"Seven years of susceptibility to marbofloxacin of bovine pathogenic strains from eight European countries","volume":"24","author":"Meunier","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2020.03.019_bib0105","first-page":"67","article-title":"Detection of the efflux pump mediated quinolone resistance in ESBL positive Escherichia coli and Klebsiella pneumonia isolates by Phe-Arg-\u03b2-Naphthylamide","volume":"1","author":"Serhat","year":"2012","journal-title":"Turk J Pharmaceut Sci"},{"key":"10.1016\/j.jgar.2020.03.019_bib0110","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/jac\/dkm204","article-title":"Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates","volume":"60","author":"Cattoir","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.03.019_bib0115","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1128\/AAC.00915-06","article-title":"Prevalence in the United States of aac(6\u2032)-Ib-cr encoding a ciprofloxacin-modifying enzyme","volume":"50","author":"Park","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.03.019_bib0120","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1128\/AAC.01137-07","article-title":"Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan","volume":"52","author":"Yamane","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.03.019_bib0125","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1128\/AAC.01574-08","article-title":"OqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae","volume":"53","author":"Kim","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.03.019_bib0130","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/jac\/dkq169","article-title":"A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica server Typhimurium and Escherichia coli","volume":"65","author":"Coldham","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.03.019_bib0135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijantimicag.2009.08.003","article-title":"Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates","volume":"35","author":"Moon","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.jgar.2020.03.019_bib0140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3855\/jidc.8574","article-title":"Detection of virulence genes in ESBL producing, quinolone resistant commensal Escherichia coli from rural Indian children","volume":"11","author":"Chandran","year":"2017","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.jgar.2020.03.019_bib0145","doi-asserted-by":"crossref","first-page":"e3168","DOI":"10.7717\/peerj.3168","article-title":"Mode of action of the 2-phenylquinoline efflux inhibitor PQQ4R against Escherichia coli","volume":"5","author":"Machado","year":"2017","journal-title":"Peer J"},{"issue":"3","key":"10.1016\/j.jgar.2020.03.019_bib0150","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/AAC.46.3.672-679.2002","article-title":"Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis","volume":"46","author":"Raherison","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.03.019_bib0155","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1128\/JB.182.6.1754-1756.2000","article-title":"AcrD of Escherichia coli is an aminoglycoside efflux pump","volume":"182","author":"Rosenberg","year":"2000","journal-title":"J Bacteriol"},{"key":"10.1016\/j.jgar.2020.03.019_bib0160","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrd2200","article-title":"Waltzing transporters and\u2019 the dance macabre between humans and bacteria","volume":"6","author":"Lomovskaya","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jgar.2020.03.019_bib0165","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ijantimicag.2007.12.015","article-title":"Demonstration of Escherichia coli K-12 AG100 by an automated ethidium bromide method","volume":"31","author":"Viveiros","year":"2008","journal-title":"Int J Antimicrobial Agents"},{"year":"2017","series-title":"WHO guidelines on use of medically important antimicrobials in food- producing animals","key":"10.1016\/j.jgar.2020.03.019_bib0170"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520300837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520300837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:56:22Z","timestamp":1761990982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716520300837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":34,"alternative-id":["S2213716520300837"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2020.03.019","relation":{},"ISSN":["2213-7165"],"issn-type":[{"type":"print","value":"2213-7165"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of marbofloxacin administration on the emergence of marbofloxacin-resistant E. coli in faecal flora of goats and elucidation of molecular basis of resistance","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2020.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}